Try our Advanced Search for more refined results

January 07, 2026

ABBVIE INC. et al v. MSN PHARMACEUTICALS INC. et al

Track this case

Case Number:

3:26-cv-00115

Court:

New Jersey

Nature of Suit:

Patent - Abbreviated New Drug Application(ANDA)

Judge:

Zahid N. Quraishi

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 08, 2026

    AbbVie Sues Over Bids To Market Generic Migraine Drugs

    AbbVie and its Allergan unit have filed patent infringement lawsuits against MSN Pharmaceuticals and Hetero in New Jersey federal court, alleging the two pharmaceutical companies are infringing on patents for the migraine drug Qulipta.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login